Nucleotide Market Scope and Size by 2031
A nucleotide is an organic molecule, which is the building block of DNA and RNA. It has functions related to metabolism, cell signaling, and enzyme reactions. The increasing application of nucleotide in several end-use industries, including food & beverage additive, pharmaceuticals, animal feed additive, and diagnostics research, augments market growth. Increasing utilization of the product in diagnostics research for identifying and testing diseases, including the presence of several viral infections or a certain type of cancer, is anticipated to propel demand in the coming years.
MARKET DYNAMICS
The global nucleotide market is witnessing considerable demand from the end-user industries. The application of nucleotides has substantially increased in animal feed additives, pharmaceuticals, the food and beverages industry, and the research and diagnostics industry. Consumers realize the negative effects of savory ingredients, and this is likely to expand the sales of nucleotide-based flavor enhancers. Moreover, the increasing application scope of nucleotide in the pharmaceuticals sector, particularly in Canada and the U.S., will spur the market progression.
MARKET SCOPE
The "Global Nucleotide Market Analysis to 2031" is a specialized and in-depth study of the chemicals and materials industry with a special focus on the global market trend analysis. The report aims to provide an overview of the nucleotide market with detailed market segmentation by nitrogeneous base, application and geography. The global nucleotide market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading nucleotide market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global nucleotide market is segmented on the basis of nitrogeneous base and application. On the basis of nitrogeneous base, nucleotide market is segmented into adenine, thymine, guanine, and cytosine. On the basis of application, market is segmented into pharmaceutical, food additive, animal feed additive, drug discovery, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global nucleotide market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America. The nucleotide market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the nucleotide market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the nucleotide market in these regions.
Have a question?
Shejal
Shejal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global nucleotide market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America. The nucleotide market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the nucleotide market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the nucleotide market in these regions.
MARKET PLAYERS
The reports cover key developments in the nucleotide market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from nucleotide market are anticipated to lucrative growth opportunities in the future with the rising demand for organic shrimps in the global market. Below mentioned is the list of few companies engaged in the nucleotide market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the nucleotide market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Biorigin
- CJ CheilJedang Corp.
- DSM
- Jena Bioscience GmbH
- Lallemand Inc.
- MEIHUA HOLDINGS GROUP CO., LTD
- Meridian Bioscience Inc.
- Promega Corporation
- STAR LAKE BIOSCIENCE
- ThermoFisher Scientific
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Nucleotide Market - By Nitrogeneous Base
1.3.2 Nucleotide Market - By Application
1.3.3 Nucleotide Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NUCLEOTIDE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NUCLEOTIDE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NUCLEOTIDE MARKET - GLOBAL MARKET ANALYSIS
6.1. NUCLEOTIDE - GLOBAL MARKET OVERVIEW
6.2. NUCLEOTIDE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. NUCLEOTIDE MARKET - REVENUE AND FORECASTS TO 2028 - NITROGENEOUS BASE
7.1. OVERVIEW
7.2. NITROGENEOUS BASE MARKET FORECASTS AND ANALYSIS
7.3. ADENINE
7.3.1. Overview
7.3.2. Adenine Market Forecast and Analysis
7.4. THYMINE
7.4.1. Overview
7.4.2. Thymine Market Forecast and Analysis
7.5. GUANINE
7.5.1. Overview
7.5.2. Guanine Market Forecast and Analysis
7.6. CYTOSINE
7.6.1. Overview
7.6.2. Cytosine Market Forecast and Analysis
8. NUCLEOTIDE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PHARMACEUTICAL
8.3.1. Overview
8.3.2. Pharmaceutical Market Forecast and Analysis
8.4. FOOD ADDITIVE
8.4.1. Overview
8.4.2. Food Additive Market Forecast and Analysis
8.5. ANIMAL FEED ADDITIVE
8.5.1. Overview
8.5.2. Animal Feed Additive Market Forecast and Analysis
8.6. DRUG DISCOVERY
8.6.1. Overview
8.6.2. Drug Discovery Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. NUCLEOTIDE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Nucleotide Market Overview
9.1.2 North America Nucleotide Market Forecasts and Analysis
9.1.3 North America Nucleotide Market Forecasts and Analysis - By Nitrogeneous Base
9.1.4 North America Nucleotide Market Forecasts and Analysis - By Application
9.1.5 North America Nucleotide Market Forecasts and Analysis - By Countries
9.1.5.1 United States Nucleotide Market
9.1.5.1.1 United States Nucleotide Market by Nitrogeneous Base
9.1.5.1.2 United States Nucleotide Market by Application
9.1.5.2 Canada Nucleotide Market
9.1.5.2.1 Canada Nucleotide Market by Nitrogeneous Base
9.1.5.2.2 Canada Nucleotide Market by Application
9.1.5.3 Mexico Nucleotide Market
9.1.5.3.1 Mexico Nucleotide Market by Nitrogeneous Base
9.1.5.3.2 Mexico Nucleotide Market by Application
9.2. EUROPE
9.2.1 Europe Nucleotide Market Overview
9.2.2 Europe Nucleotide Market Forecasts and Analysis
9.2.3 Europe Nucleotide Market Forecasts and Analysis - By Nitrogeneous Base
9.2.4 Europe Nucleotide Market Forecasts and Analysis - By Application
9.2.5 Europe Nucleotide Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Nucleotide Market
9.2.5.1.1 Germany Nucleotide Market by Nitrogeneous Base
9.2.5.1.2 Germany Nucleotide Market by Application
9.2.5.2 France Nucleotide Market
9.2.5.2.1 France Nucleotide Market by Nitrogeneous Base
9.2.5.2.2 France Nucleotide Market by Application
9.2.5.3 Italy Nucleotide Market
9.2.5.3.1 Italy Nucleotide Market by Nitrogeneous Base
9.2.5.3.2 Italy Nucleotide Market by Application
9.2.5.4 United Kingdom Nucleotide Market
9.2.5.4.1 United Kingdom Nucleotide Market by Nitrogeneous Base
9.2.5.4.2 United Kingdom Nucleotide Market by Application
9.2.5.5 Russia Nucleotide Market
9.2.5.5.1 Russia Nucleotide Market by Nitrogeneous Base
9.2.5.5.2 Russia Nucleotide Market by Application
9.2.5.6 Rest of Europe Nucleotide Market
9.2.5.6.1 Rest of Europe Nucleotide Market by Nitrogeneous Base
9.2.5.6.2 Rest of Europe Nucleotide Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Nucleotide Market Overview
9.3.2 Asia-Pacific Nucleotide Market Forecasts and Analysis
9.3.3 Asia-Pacific Nucleotide Market Forecasts and Analysis - By Nitrogeneous Base
9.3.4 Asia-Pacific Nucleotide Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Nucleotide Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Nucleotide Market
9.3.5.1.1 Australia Nucleotide Market by Nitrogeneous Base
9.3.5.1.2 Australia Nucleotide Market by Application
9.3.5.2 China Nucleotide Market
9.3.5.2.1 China Nucleotide Market by Nitrogeneous Base
9.3.5.2.2 China Nucleotide Market by Application
9.3.5.3 India Nucleotide Market
9.3.5.3.1 India Nucleotide Market by Nitrogeneous Base
9.3.5.3.2 India Nucleotide Market by Application
9.3.5.4 Japan Nucleotide Market
9.3.5.4.1 Japan Nucleotide Market by Nitrogeneous Base
9.3.5.4.2 Japan Nucleotide Market by Application
9.3.5.5 South Korea Nucleotide Market
9.3.5.5.1 South Korea Nucleotide Market by Nitrogeneous Base
9.3.5.5.2 South Korea Nucleotide Market by Application
9.3.5.6 Rest of Asia-Pacific Nucleotide Market
9.3.5.6.1 Rest of Asia-Pacific Nucleotide Market by Nitrogeneous Base
9.3.5.6.2 Rest of Asia-Pacific Nucleotide Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Nucleotide Market Overview
9.4.2 Middle East and Africa Nucleotide Market Forecasts and Analysis
9.4.3 Middle East and Africa Nucleotide Market Forecasts and Analysis - By Nitrogeneous Base
9.4.4 Middle East and Africa Nucleotide Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Nucleotide Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Nucleotide Market
9.4.5.1.1 South Africa Nucleotide Market by Nitrogeneous Base
9.4.5.1.2 South Africa Nucleotide Market by Application
9.4.5.2 Saudi Arabia Nucleotide Market
9.4.5.2.1 Saudi Arabia Nucleotide Market by Nitrogeneous Base
9.4.5.2.2 Saudi Arabia Nucleotide Market by Application
9.4.5.3 U.A.E Nucleotide Market
9.4.5.3.1 U.A.E Nucleotide Market by Nitrogeneous Base
9.4.5.3.2 U.A.E Nucleotide Market by Application
9.4.5.4 Rest of Middle East and Africa Nucleotide Market
9.4.5.4.1 Rest of Middle East and Africa Nucleotide Market by Nitrogeneous Base
9.4.5.4.2 Rest of Middle East and Africa Nucleotide Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Nucleotide Market Overview
9.5.2 South and Central America Nucleotide Market Forecasts and Analysis
9.5.3 South and Central America Nucleotide Market Forecasts and Analysis - By Nitrogeneous Base
9.5.4 South and Central America Nucleotide Market Forecasts and Analysis - By Application
9.5.5 South and Central America Nucleotide Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Nucleotide Market
9.5.5.1.1 Brazil Nucleotide Market by Nitrogeneous Base
9.5.5.1.2 Brazil Nucleotide Market by Application
9.5.5.2 Argentina Nucleotide Market
9.5.5.2.1 Argentina Nucleotide Market by Nitrogeneous Base
9.5.5.2.2 Argentina Nucleotide Market by Application
9.5.5.3 Rest of South and Central America Nucleotide Market
9.5.5.3.1 Rest of South and Central America Nucleotide Market by Nitrogeneous Base
9.5.5.3.2 Rest of South and Central America Nucleotide Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. NUCLEOTIDE MARKET, KEY COMPANY PROFILES
11.1. BIORIGIN
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. CJ CHEILJEDANG CORP.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. DSM
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. JENA BIOSCIENCE GMBH
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LALLEMAND INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MEIHUA HOLDINGS GROUP CO., LTD
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MERIDIAN BIOSCIENCE INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PROMEGA CORPORATION
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. STAR LAKE BIOSCIENCE
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. THERMOFISHER SCIENTIFIC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Biorigin
2. CJ CheilJedang Corp.
3. DSM
4. Jena Bioscience GmbH
5. Lallemand Inc.
6. MEIHUA HOLDINGS GROUP CO., LTD
7. Meridian Bioscience Inc.
8. Promega Corporation
9. STAR LAKE BIOSCIENCE
10. ThermoFisher Scientific
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For